Cargando…
Dramatic Clinical Response of Relapsed Metastatic Extramammary Paget's Disease to Trastuzumab Monotherapy
We report the first case of 68-year-old Japanese woman with metastatic HER2-positive extramammary Paget's disease that showed the validity of trastuzumab monotherapy. We administered trastuzumab at a loading dose of 8 mg/kg i.v., followed by a 6 mg/kg maintenance dose every three weeks accordin...
Autores principales: | Wakabayashi, S., Togawa, Y., Yoneyama, K., Suehiro, K., Kambe, N., Matsue, H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505941/ https://www.ncbi.nlm.nih.gov/pubmed/23259081 http://dx.doi.org/10.1155/2012/401362 |
Ejemplares similares
-
A Case of Metastatic Extramammary Paget's Disease Responding to Trastuzumab plus Paclitaxel Combination Therapy
por: Hanawa, Fumie, et al.
Publicado: (2011) -
The Outcome of Chemotherapy for Metastatic Extramammary Paget’s Disease
por: Hashimoto, Hiroki, et al.
Publicado: (2021) -
Extramammary Paget’s disease
por: Vasquez, Andres, et al.
Publicado: (2016) -
Extramammary Perianal Paget's Disease
por: Al Hallak, M.N., et al.
Publicado: (2009) -
Mammary and extramammary Paget's disease()
por: Lopes, Lauro Lourival, et al.
Publicado: (2015)